The presence of certain microbes was associated with major shifts in tumor gene activity and the immune environment around the cancer.
Julie Rodriguez, researcher at Inserm (National Institute of Health and Medical Research, France) explored the main categories of microbiome-based biomarkers and their potential applications in clinical practice.
Targeting the gut microbiota-ergothioneine pathway may offer a new way to prevent or treat cognitive side effects of antipsychotic drugs.
Supplementing creatine alongside specific gut bacteria such as Bifidobacterium could offer a treatment for depression by restoring brain energy metabolism.
Marta Ciechonska of Salient Bioscience presented the company’s approach to developing standardized, reproducible microbiome tests based on shotgun metagenomic sequencing.
Reducing dietary fat or controlling gut inflammation could help preserve immune cells and protect gut immunity, offering a strategy to prevent diet-related gut diseases.
Maintaining a healthy gut barrier and microbiota, through diet or other interventions, could help prevent bacteria from reaching the brain, helping maintain neurological health.
Gut microbiota, immunity and diet: twenty years of research and the future of personalized nutrition
Francisco Guarner, from Centro Médico Teknon in Barcelona (Spain), discussed the most recent researches in the field of microbiome and nutrition.
Boosting the gut metabolite indoleacrylic acid (IA), either directly or through the probiotic Bifidobacterium longum subsp. infantis, help protect the gut and prevent NEC.
Using probiotics such as LACTIN-V after antibiotic treatment could help prevent bacterial vaginosis, opening the way for tailored treatments based on individual microbiota profiles.
